US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Fidelity MSCI Health Care Index ETF

81.29

+0.69000.86%

Post-market: 81.290.00000.00%16:10 EDT

Volume:200.13K

Turnover:16.21M

Market Cap:3.52B

PE:- -

High:81.45

Open:80.54

Low:80.42

Close:80.60

52wk High:85.46

52wk Low:67.77

Shares:43.35M

Float Shares:43.35M

Volume Ratio:0.44

T/O Rate:0.46%

Dividend:1.02

Dividend Rate:1.25%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors

Correction: Top Midday Decliners

MT Newswires Live

Abogen announces licensing, option agreement with Novartis

Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study

Johnson & Johnson Says Icotyde Sustains Psoriasis Skin Clearance Through 2 Years in Phase 3 Iconic-TOTAL Study

J&J - Icotyde-Treated Patients Show 70% Clear or Almost Clear Skin at Week 112

THOMSON REUTERS

Johnson & Johnson Announces New Icotyde® (Icotrokinra) Data in Difficult-to-Treat Plaque Psoriasis with Proven Durability Through 2-Years, Affirming Its Use as a Powerful First Line Systemic Therapy~

THOMSON REUTERS

J&J - 60% Scalp Psoriasis, 89% Genital Psoriasis Patients Achieve Complete Clearance at Week 112

THOMSON REUTERS

J&J - Safety Findings Through Week 112 Consistent with Icotyde Profile, no New Safety Signals

THOMSON REUTERS

Major Drugmakers Turn to China for Licensing Deals

Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals

Novartis Strikes up to $7.8 Billion mRNA Deal with China's Abogen

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Sector Update: Healthcare

MT Newswires Live

AbbVie (ABBV) Stock May Be 41% Undervalued On FDA Approval

Simply Wall St.

Trump Medicare Drug Pricing Model May Apply to Only Four Companies After Exemptions

Merck's Tulisokibart Data From Hidradenitis Suppurativa Trial Looks Solid, UBS Securities Says

MT Newswires Live

Eli Lilly's Obesity Data Support Broader Portfolio Beyond Tirzepatide, UBS Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/FHLC/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FHLC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FHLC\",,,,,undefined,":{"symbol":"FHLC","market":"US","secType":"STK","nameCN":"Fidelity MSCI Health Care Index ETF","latestPrice":81.29,"timestamp":1791230400000,"preClose":80.6,"halted":0,"volume":200125,"hourTrading":{"tag":"盘后","latestPrice":81.29,"preClose":81.29,"latestTime":"16:10 EDT","volume":16,"amount":1299.93008,"timestamp":1791231005628,"change":0,"changeRate":0,"amplitude":0.008734},"delay":0,"changeRate":0.00856079404466516,"floatShares":43350000,"shares":43350000,"eps":0,"marketStatus":"Post-Mkt","change":0.69,"latestTime":"10-05 16:13:17 EDT","open":80.54,"high":81.45,"low":80.42,"amount":16212460.458749998,"amplitude":0.012779,"askPrice":88.93,"askSize":100,"bidPrice":80.8,"bidSize":300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791244800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":80.6,"sharesOutstanding":39450000,"nav":80.567556,"aum":3569142730.8,"dividendRate":0.012494,"bidAskSpread":0.0004,"preHourTrading":{"tag":"盘前","latestPrice":80.6,"preClose":80.6,"latestTime":"08:12 EDT","volume":23,"amount":1838.6002199999998,"timestamp":1791202360472,"change":0,"changeRate":0,"amplitude":0.009926},"postHourTrading":{"tag":"盘后","latestPrice":81.29,"preClose":81.29,"latestTime":"16:10 EDT","volume":16,"amount":1299.93008,"timestamp":1791231005628,"change":0,"changeRate":0,"amplitude":0.008734},"volumeRatio":0.442429,"impliedVol":0.155,"impliedVolPercentile":0.8685},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FHLC\",,,,,undefined,":{"symbol":"FHLC","floatShares":43350000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.442429,"shares":43350000,"dividePrice":1.0156,"high":81.45,"amplitude":0.012779,"preClose":80.6,"low":80.42,"week52Low":67.772,"pbRate":"--","week52High":85.4649,"institutionHeld":0,"latestPrice":81.29,"committee":0.5,"eps":0,"divideRate":0.012494,"volume":200125,"delay":0,"ttmEps":0,"open":80.54,"prevYearClose":74.28,"prevWeekClose":80.6,"prevMonthClose":81.7,"prevQuarterClose":81.7,"fiveDayClose":82.92,"twentyDayClose":83.14,"sixtyDayClose":78.405},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FHLC\",params:#limit:5,,,undefined,":[{"date":"2026-09-18","symbol":"FHLC","amount":0.254,"announcedDate":"2026-09-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-18","defaultRemindTime":1789738200000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-22","payableDate":"2026-09-18","currency":"USD","dateTimestamp":1789704000000,"payDate":"2026-09-22"},{"date":"2026-06-18","symbol":"FHLC","amount":0.263,"announcedDate":"2026-06-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-18","defaultRemindTime":1781789400000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-18","currency":"USD","dateTimestamp":1781755200000,"payDate":"2026-06-23"},{"date":"2026-03-20","symbol":"FHLC","amount":0.229,"announcedDate":"2026-03-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-20","defaultRemindTime":1774013400000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-24","payableDate":"2026-03-20","currency":"USD","dateTimestamp":1773979200000,"payDate":"2026-03-24"},{"date":"2025-12-19","symbol":"FHLC","amount":0.272,"announcedDate":"2025-12-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-19","defaultRemindTime":1766154600000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-19","currency":"USD","dateTimestamp":1766120400000,"payDate":"2025-12-23"},{"date":"2025-09-19","symbol":"FHLC","amount":0.256,"announcedDate":"2025-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-19","defaultRemindTime":1758288600000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-19","currency":"USD","dateTimestamp":1758254400000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FHLC\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-22","value":0.117,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-23","value":0.125,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-22","value":0.137,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-20","value":0.132,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-21","value":0.134,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FHLC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FHLC\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672743169","title":"AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672743169","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672743169?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:30","pubTimestamp":1790958623,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s latest study, NCT05317494, tracks how its leukemia drug Venetoclax wor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-venetoclax-aml-study-in-greece-what-the-latest-update-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-venetoclax-aml-study-in-greece-what-the-latest-update-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2125909247.SGD","IE00BN8TJ469.HKD","LU1732799900.SGD","IE00BSNM7G36.USD","VHT","LU0170899867.USD","SG9999011175.SGD","IYH","LU1934455863.HKD","RXL","ABBV","LU0985320562.USD","LU1244550494.USD","LU1989771016.USD","LU1839511570.USD","LU0310800379.SGD","FHLC","LU2133065610.SGD","LU0289739699.SGD","LU0942090050.USD","TRUH","LU2129689605.HKD","LU0965509010.AUD","GLAM","LU0310799852.SGD","IE00BLSP4452.SGD","ISBC","MEDX","LU0198837287.USD","LU1989772840.SGD","LU0289961442.SGD","FTXH","LU0395794307.EUR","PJP","LU0029864427.USD","XLV","JDOC","IXJ","IE00BDGV0183.EUR","IE00BVYPNW00.USD","LU0234572021.USD","AGNG","IE0002270589.USD","PPH","LU1023059063.AUD","IE00B19Z3581.USD","LU2237443549.SGD","IE00B42XCP33.USD","LU2023251221.USD","LU2129689514.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672339714","title":"Correction: Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2672339714","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672339714?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:22","pubTimestamp":1790943727,"startTime":"0","endTime":"0","summary":"Corteva  said Thursday that a federal court denied California's request to temporarily block the planned separation of its seed business into a new publicly traded company, Vylor .In a separate announcement, Vylor said it completed its separation from Corteva and will begin trading as an independent public company on the New York Stock Exchange.Corteva shares slumped 84% as intraday trading volume catapulted to nearly 63.5 million from a daily average of about 4.45 million.Foghorn Therapeutics  and Eli Lilly  have decided not to advance FHD-909  into the clinical development expansion phase after reviewing clinical data from a phase 1 dose escalation trial.Foghorn shares sank 20% as intraday trading volume soared to nearly 11.8 million from a daily average of roughly 380,000.Paramount Skydance  CEO David Ellison has asked CNN CEO Mark Thompson to continue after Paramount completes its acquisition of Warner Bros. Discovery , The Wall Street Journal reported Thursday, citing people famil","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0009355771.USD","IE00B2B36J28.USD","PYZ","LU0823434583.USD","LU0316494557.USD","LU0256863902.USD","LU0109394709.USD","IE00BFSS8Q28.SGD","IE00BN29S564.USD","LU0225283273.USD","LU2089283258.USD","LU2211815571.USD","LU0640476718.USD","LU1814569148.SGD","LU2168563687.JPY","LU2271345857.HKD","LU0109391861.USD","LU2023251221.USD","PBJ","SG9999002521.SGD","SG9999014898.SGD","LU2471134952.CNY","CURE","LU2750360641.GBP","WBD","FTXH","LU0353189680.USD","LU0823434740.USD","LU0122379950.USD","ELIS","LU0820561818.USD","SG9999018865.SGD","LU0094547139.USD","LU0477156953.USD","SG9999013999.USD","LU2168564495.EUR","LU0612318971.USD","IE00B775H168.HKD","IE00BFSS7M15.SGD","VHT","LU0079474960.USD","IYH","LU2746668461.USD","LU2756315318.SGD","LU1868836591.USD","LU2087625088.SGD","LU2168564065.EUR","BK4585","LU0006306889.USD","LU0353189763.USD","LU0354030511.USD","LU1979441026.SGD","BK4139","LU2462157665.USD","LU1917777945.USD","LU0654597011.USD","LU1035775433.USD","LU2063271972.USD","IE00BJT1NW94.SGD","LU0345781412.USD","LU1366192091.USD","SKYD","IE00B4R5TH58.HKD","LU1201861249.SGD","ILDR","LU0256863811.USD","BK4581","BK4125","SG9999018857.SGD","SGXZ31699556.SGD","LLYX","LU1548497426.USD","LU2552382132.HKD","WDNA","LU1323610961.USD","LU2896262040.SGD","FHLC","LU1145028129.USD","LU0203202063.USD","IE00BJLML261.HKD","LU0097036916.USD","SG9999001176.USD","LU0471298777.SGD","LU1720051017.SGD","LU2602419157.SGD","FTAG","LU2552382058.USD","IE00BKDWB100.SGD","LU1974910355.USD","LU1291159041.SGD","LU2023250330.USD","LU0266013472.USD","LU2023250504.SGD","LLII","BK4093","LU0630314457.HKD","LU2111349929.HKD","LU0823416689.USD","IXJ","LU0889565916.HKD","LU0964807845.USD","PPH","LU0417517546.SGD","LU0648001328.SGD","IE00B4JS1V06.HKD","LU0203201768.USD","LLYZ","MEDX","LU0345770308.USD","LU0689472784.USD","LU2456880835.USD","LU2211817866.USD","PJP","LU0130517989.USD","LU2491050154.USD","LU1868837136.USD","LU1983299246.USD","LU1093756325.SGD","BK4533","LU1551013342.USD","RXL","LU0289739699.SGD","LU0787776722.HKD","THNR","VYLR","IE00BKPKM429.USD","IE0004445239.USD","LU1064131342.USD","IE00BJJMRY28.SGD","LU0106261372.USD","LU0323591593.USD","LU1232071149.USD","LU2237443978.SGD","HRTS","LU0130102774.USD","LU0320765992.SGD","IE00BK4W5L77.USD","LU2756315664.SGD","BK4598","SG9999001176.SGD","LU2028103732.USD","LU1061106388.HKD","LU1551013425.SGD","ELIL","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU0943347566.SGD","LU1868836914.USD","IE00BK4W5M84.HKD","LU1804176565.USD","MHIP","LU2264538146.SGD","LU2361044865.SGD","LU0456855351.SGD","LU0471298694.HKD","LU2361045086.USD","LU0096364046.USD","LU1506573853.SGD","LU1720051108.HKD","LU0385154629.USD","LU0882574139.USD","IE0005OL40V9.USD","LU2361044949.HKD","LU2237438978.USD","SG9999014906.USD","JDOC","BK4599","SGXZ99366536.SGD","LU2461242641.AUD","BK4534","LU2324357040.USD","LU2112291526.USD","BK4588","LU0149725797.USD","BK4007","LU2750360997.AUD","LU0980610538.SGD","LU1127390331.HKD","LU2106854487.HKD","LU2236285917.USD","IE00BJJMRX11.SGD","LU0320765059.SGD","IE0004445015.USD","LU0300736062.USD","LU1629891620.HKD","CTVA","CANC","LU0158827948.USD","LU0238689110.USD","LU0345770993.USD","LU1868836757.USD","LU1691799644.USD","SGXZ81514606.USD","LU2468319806.SGD","IE00B7KXQ091.USD","LU0672654240.SGD","BK4516","LU0882574055.USD","PSKY","TRUH","LU0466842654.USD","LU0786609619.USD","IE00B1BXHZ80.USD","LU1280957306.USD","LU2089984988.USD","LU2237443622.USD","LU2746668974.SGD","LU0820562030.AUD","LU1712237335.SGD","LU1093756168.USD","LU0114720955.EUR","LU0058720904.USD","LU2213496289.HKD","LU1988902786.USD","LU2491049909.HKD","AGNG","LU1430597077.USD","SG9999015986.USD","TMED","LU2168564222.USD","SGXZ51526630.SGD","LU0158827781.USD","LU0234572021.USD","LU0061475181.USD","LU0174119429.USD","LU0354030438.USD","LU2237443465.HKD","LU1057294990.SGD","LU2237443549.SGD","SG9999015978.USD","LU1989771016.USD","LU2471134523.USD","VEGI","LU0820561909.HKD","LU0345780950.USD","LU1267930730.SGD","LU0133085943.USD","SG9999014880.SGD","IE0002141913.USD","LU2108987350.USD","IE00BJJMRZ35.SGD","LU2168564149.EUR","LU2417539215.USD","LU0198837287.USD","LU2471134796.USD","SG9999015945.SGD","LU0612318385.USD","LU0210536198.USD","LU2491050071.SGD","IE00B1XK9C88.USD","LU2237443382.USD","LLY","GDOC","IE00BWXC8680.SGD","LU2462591350.SGD","SGXZ57979304.SGD","XLV","LU2089284900.SGD","LU0300736492.USD","LU2360106947.USD","FHTX","SG9999014914.USD","GB00BDT5M118.USD","LU2237443895.HKD","MEDI","LU2357305700.SGD","LU2471134879.HKD","SG9999017495.SGD","LU2265009873.SGD","LU0683600562.USD","LU0708995401.HKD","LU0432979614.USD","LU1623119135.USD","OZEM","SG9999015952.SGD","LU1868837300.USD","BK4108","LU1023059063.AUD","IHE","LU2552382215.SGD","KROP","BK4535","IE0001KFT4U8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672163957","title":"Abogen announces licensing, option agreement with Novartis","url":"https://stock-news.laohu8.com/highlight/detail?id=2672163957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672163957?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:10","pubTimestamp":1790935812,"startTime":"0","endTime":"0","summary":"Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, announced that it has entered into a licensing and option agree...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","FHLC","AGNG","BBP","BBC","SYNB","XT","JDOC","BK4588","LNGR","IBB","BK4585","BK4139","RSPH","FWD","IEIH","RNA","IE0009354923.USD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672716311","title":"Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672716311","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672716311?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:05","pubTimestamp":1790935529,"startTime":"0","endTime":"0","summary":"Johnson & Johnson announced new two-year data from the Phase 3 ICONIC-TOTAL study demonstrating the positive impact of ICOTYDE on high-impact plaqu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-announces-two-year-data-from-phase-3-iconic-total-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-announces-two-year-data-from-phase-3-iconic-total-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYH","LU0640476718.USD","LU2468319806.SGD","JDOC","IE00B19Z3B42.SGD","FHLC","LU2430703251.USD","RXL","TRUH","LU0234570918.USD","IE00BDGV0183.EUR","LU1043141396.HKD","GDOC","JNJ","LU0738911758.USD","LU2236285917.USD","XLV","IHE","LU2505996509.AUD","BK4581","BK4588","LU0203345920.USD","IE00B2B36J28.USD","LU1732800096.USD","BK4534","LU2471134952.CNY","LU2896262040.SGD","SGXZ57979304.SGD","MEDX","BMED","LU0426412945.USD","IXJ","PJP","IE0002270589.USD","BK4592","LU1551013425.SGD","LU2417539215.USD","LU1066053197.SGD","LU1551013342.USD","SG9999013999.USD","LU1496350502.SGD","VHT","IE000M9KFDE8.USD","IE00BJT1NW94.SGD","LU0162691827.USD","FTXH","SG9999002224.SGD","IE000WAW04H5.SGD","LU0466842654.USD","LU0994945656.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715109","title":"Johnson & Johnson Says Icotyde Sustains Psoriasis Skin Clearance Through 2 Years in Phase 3 Iconic-TOTAL Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715109","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715109?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:01","pubTimestamp":1790935267,"startTime":"0","endTime":"0","summary":"Johnson & Johnson says ICOTYDE sustains psoriasis skin clearance through 2 years in Phase 3 ICONIC-TOTAL studyJohnson & Johnson disclosed new two-year Phase 3 ICONIC-TOTAL results for ICOTYDE (icotrok","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL8bWfkV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","LU1732800096.USD","SG9999002224.SGD","LU2430703251.USD","LU1629891620.HKD","IYH","XLV","LU0994945656.USD","LU1674673691.USD","LU2456880835.USD","LU2417539215.USD","LU0426412945.USD","IHE","LU0820561818.USD","IE0034235303.USD","LU1061106388.HKD","SG9999001440.SGD","RXL","IE00BLSP4452.SGD","TRUH","LU2129689605.HKD","FTXH","IXJ","LU0738911758.USD","IE00BSNM7G36.USD","PJP","IE0009355771.USD","BMED","MEDX","LU0072461881.USD","LU1066051225.USD","BK4592","LU0545039389.USD","IE00BBT3K403.USD","LU0234572021.USD","VHT","LU1430594728.SGD","LU1043141123.HKD","JDOC","LU1066051811.HKD","LU1043141396.HKD","GDOC","IE00B4R5TH58.HKD","LU2896262040.SGD","LU0162691827.USD","IE0000B7K699.USD","FHLC","SG9999001176.USD","IE00BJT1NW94.SGD","LU2347655156.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672971590","title":"J&J - Icotyde-Treated Patients Show 70% Clear or Almost Clear Skin at Week 112","url":"https://stock-news.laohu8.com/highlight/detail?id=2672971590","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672971590?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0057025933.USD","LU1551013425.SGD","LU1221951046.USD","MEDX","LU2129689605.HKD","FTXH","IE0001KFT4U8.USD","TRUH","LU1121112475.USD","LU1162221912.USD","LU0882574055.USD","BK4581","IHE","VHT","LU0426417589.USD","SGXZ80539844.SGD","LU0820562030.AUD","LU1061106388.HKD","IE00B19Z3581.USD","GDOC","LU0162691827.USD","BK4568","FHLC","LU0795875169.SGD","LU1989771016.USD","JNJ","IE00B4R5TH58.HKD","BMED","LU0912757837.SGD","LU1551013342.USD","LU0320765646.SGD","XLV","IXJ","LU1935042991.SGD","LU0820561909.HKD","JDOC","LU2592432038.USD","IYH","LU0234572021.USD","PJP","LU1496350502.SGD","LU2347655156.SGD","LU1066051498.USD","LU1674673691.USD","LU0426412945.USD","IE00BLSP4452.SGD","IE00BFTCPJ56.SGD","LU0072461881.USD","LU2471134879.HKD","RXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672900715","title":"Johnson & Johnson Announces New Icotyde® (Icotrokinra) Data in Difficult-to-Treat Plaque Psoriasis with Proven Durability Through 2-Years, Affirming Its Use as a Powerful First Line Systemic Therapy~","url":"https://stock-news.laohu8.com/highlight/detail?id=2672900715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672900715?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FHLC","XLV","LU0234570918.USD","LU0889566641.SGD","IXJ","JDOC","IE00BKVL7J92.USD","LU0795875086.SGD","LU1989771016.USD","FTXH","VHT","LU1003077747.HKD","LU1221951129.SGD","BK4550","IE00BVYPNV92.GBP","IE00BGHQF631.EUR","LU0070217475.USD","LU0203347892.USD","BK4568","IHE","LU1674673691.USD","BK4581","IE00BVYPNW00.USD","IYH","LU0820561909.HKD","LU0122379950.USD","LU0472753341.HKD","LU2750360641.GBP","LU0511384066.AUD","BMED","RXL","IE00BSNM7G36.USD","IE0009355771.USD","LU0203345920.USD","LU0792757196.USD","LU0820562030.AUD","LU1066053197.SGD","JNJ","MEDX","LU1551013342.USD","LU1228905037.USD","GDOC","LU1430594728.SGD","IE00BDGV0183.EUR","PJP","LU1267930813.SGD","TRUH","LU1066051225.USD","LU0882574055.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715972","title":"J&J - 60% Scalp Psoriasis, 89% Genital Psoriasis Patients Achieve Complete Clearance at Week 112","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715972?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","LU0345770993.USD","LU1074936037.SGD","IHE","LU1267930813.SGD","FTXH","IXJ","BMED","JDOC","IE000MB6IJN5.SGD","LU1983299246.USD","GDOC","TRUH","LU0882574055.USD","LU1145028129.USD","LU0203347892.USD","LU2471134879.HKD","VHT","LU0210528500.USD","BK4581","IYH","LU2456880835.USD","IE000F7OJYX1.SGD","LU1914381329.SGD","FHLC","LU0162691827.USD","BK4588","LU0072461881.USD","LU0545562505.USD","LU2129689514.USD","PJP","RXL","IE000BZT7R73.USD","LU0820562030.AUD","XLV","IE00BFTCPJ56.SGD","IE000M9KFDE8.USD","LU0345769128.USD","JNJ","LU0964807845.USD","SG9999002232.USD","LU1221951129.SGD","LU2505996681.GBP","LU1732800096.USD","LU1043141123.HKD","LU1551013425.SGD","IE00BN8TJ469.HKD","IE00B1BXHZ80.USD","LU1506573853.SGD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672171597","title":"J&J - Safety Findings Through Week 112 Consistent with Icotyde Profile, no New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672171597","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672171597?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0795875086.SGD","LU0070217475.USD","LU1003077747.HKD","LU0792757196.USD","LU0820562030.AUD","LU0203345920.USD","LU1674673691.USD","BK4550","LU0882574055.USD","LU0472753341.HKD","LU0122379950.USD","IHE","LU0234570918.USD","JNJ","XLV","LU1221951129.SGD","BK4581","LU1430594728.SGD","GDOC","LU2750360641.GBP","VHT","LU0889566641.SGD","IE00BVYPNW00.USD","FTXH","LU0820561909.HKD","TRUH","IYH","LU1066053197.SGD","MEDX","BK4568","LU0203347892.USD","FHLC","IXJ","IE00BDGV0183.EUR","IE00BGHQF631.EUR","LU1066051225.USD","LU0432979614.USD","LU0511384066.AUD","PJP","LU1551013342.USD","RXL","JDOC","IE00BKVL7J92.USD","IE00BVYPNV92.GBP","LU1267930813.SGD","LU1228905037.USD","LU1989771016.USD","IE00BSNM7G36.USD","IE0009355771.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715686","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715686?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:50","pubTimestamp":1790934645,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsOct 2 (Reuters)-Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Swiss drugmaker NovartisNOVN.Sto develop an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","SG9999014880.SGD","IE00BFXG1179.USD","KURE","BK1587","LU2023250504.SGD","LU2293690249.USD","IE00B1BXHZ80.USD","LU0827474353.SGD","SG9999015945.SGD","LU0784383803.USD","LU1366192091.USD","LU0124676726.USD","LU1481599808.USD","IE00B19Z3581.USD","LU0320765646.SGD","IE00B3PB1722.GBP","LU2750360997.AUD","BK4551","LU0390134368.USD","LU1035775433.USD","LU1487256676.USD","LU0661504455.SGD","LU0348827113.USD","LU1280957306.USD","LU1267930227.SGD","LU2361044949.HKD","LU2399975544.HKD","LU0057025933.USD","LU0106261372.USD","LU0306806265.USD","LU2125909593.SGD","LU1670628061.USD","IE00B543WZ88.USD","BK0239","MHIP","LU0501845795.SGD","LU2433249047.HKD","BK4592","LU2488822045.USD","HCM","LU1883839398.USD","LU0348784397.USD","LU0353189680.USD","LU0965508806.USD","IE0005OL40V9.USD","LU0887340254.USD","LU0203345920.USD","LU0321505439.SGD","ILDR","LU1732799900.SGD","LU1302929846.USD","LU0820561818.USD","LU0203201768.USD","LU0889566641.SGD","600276","LU0348825331.USD","LU1051770623.HKD","LU1496350171.SGD","SG9999014559.SGD","LU2097828557.USD","BK0196","LU0969580561.USD","LU0417516738.SGD","LU1496350502.SGD","LU2168564495.EUR","IXJ","VHT","LU0526926950.USD","LU0244354667.USD","01093","LU0079474960.USD","LU1328277881.USD","LU2462157665.USD","LU0354030438.USD","LU1188198961.HKD","IE00B42XCP33.USD","LU0882574139.USD","LU2097828474.EUR","SGXZ31699556.SGD","LU1781817850.SGD","IE00BLSP4239.USD","LU0708994859.HKD","LU1934455277.USD","BK4568","LU2539964713.USD","LU1718418525.SGD","LU0889565916.HKD","LU0128525929.USD","LU1997245094.SGD","IE00BKDWB100.SGD","LU0964806797.USD","LU2360032135.SGD","NVOH","IE0008369823.USD","NVO","IYH","LU1226287529.USD","LU2108987350.USD","LU0211331839.USD","LU0011850046.USD","LU1868836591.USD","LU2289578879.USD","NVOX","SG9999002232.USD","IE00BZ1G4Q59.USD","LU1153584641.USD","LU0943347566.SGD","SG9999001440.SGD","SG9999001176.USD","LU0289961442.SGD","LU0047473722.SGD","LU1969619763.USD","IE00BDGV0183.EUR","LU2324357040.USD","IE00B031HY20.USD","IE00BK4W5M84.HKD","LU2168564222.USD","ELIL","LU1064131003.USD","IHE","LU0211326755.USD","LU2495084118.USD","LU0980610538.SGD","LU0353189763.USD","LU1989772840.SGD","LU1839511570.USD","LU0345777659.USD","HRTS","LU0964807845.USD","LU0640478417.SGD","LU0225284248.USD","LU2063271972.USD","IE00B2B36J28.USD","LU0965509283.SGD","LU2091194634.USD","LU2552382058.USD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2461242641.AUD","SGXZ57979304.SGD","IE0002141913.USD","BK4559","LU0053666078.USD","LU2646069778.SGD","IBBQ","LU0823434740.USD","LU1670627923.USD","LU2756315318.SGD","LU2028103732.USD","LU1960683339.HKD","LU2125154778.USD","BK1589","BK1588","LU0348767384.USD","LU0061475181.USD","IE00BKPKM643.USD","LU1003076772.USD","BK4578","LU0784385840.USD","LU0114720955.EUR","LU0405327148.USD","LU0234570918.USD","LU0784385170.HKD","LU1226288253.USD","IE0008368742.USD","LU0256863811.USD","LU0949170772.SGD","BK0028","PPH","GLAM","LU2355687059.USD","LU1894683264.USD","LU1988902786.USD","SG9999015358.SGD","LU0472753341.HKD","LU1032466523.USD","IE000BZT7R73.USD","LU1145028129.USD","LU2097828805.USD","LU0976567544.SGD","LU2491049909.HKD","LU1670711040.USD","SG9999015986.USD","LU1046234339.USD","688331","LU0502904849.HKD","LU0405327494.USD","LU1868836914.USD","LU0171276677.USD","LU1236620750.USD","LU0634319403.HKD","LU1997244956.HKD","SG9999011175.SGD","LU2129689605.HKD","IE00BJT1NW94.SGD","LU0348766576.USD","LU0432979614.USD","LU1400636574.HKD","LU1228905540.USD","LU1309081286.SGD","REGN","MEDI","BK4585","IE00BLSP4452.SGD","LU2125909247.SGD","LU2242646821.SGD","SG9999017495.SGD","LU0237698245.USD","IE00BWXC8680.SGD","LU0912757837.SGD","LU1023059063.AUD","LU1153585028.USD","688506","LU1993786604.SGD","LU1894683348.USD","LU0130517989.USD","LU0069063385.USD","IE00B3M56506.USD","LU1228905037.USD","LU1064927863.SGD","LU0345770308.USD","LU1244550221.USD","LU1941712264.USD","LU1655091616.SGD","GSK.UK","LU1355424745.HKD","LU1863844749.USD","TMED","BK5011","BK0183","LU2750360641.GBP","SGXZ51526630.SGD","LU0047473722.EUR","LU0072913022.USD","LU2237443549.SGD","LU0545562505.USD","LU2596442595.SGD","LU2471134879.HKD","LU2293690082.USD","IE0002270589.USD","LU0162691827.USD","IE00BZ08YS42.EUR","LU0354030511.USD","LU0154236417.USD","LU0267386448.USD","LU1863844665.USD","LU0757432116.USD","LU2089283258.USD","LU2357627491.SGD","LU0067412154.USD","LU0965509101.SGD","LU1580142542.USD","LLY","LU0795875086.SGD","LU1868837300.USD","IE00BWDBJ516.SGD","LU1623119135.USD","IE00BK4W5L77.USD","LU1226287875.USD","LU0320765992.SGD","LU0456855351.SGD","LU2362540622.SGD","SG9999014906.USD","AGNG","LU0972486137.USD","LU1003077747.HKD","LU1481600234.SGD","MRK","LU0070302665.USD","CURE","LU1069347547.HKD","LU1255011170.USD","LU0861579265.USD","LU0640476718.USD","LU0557290698.USD","LU3187612489.SGD","LU2129689514.USD","LU1923622614.USD","LU1084165304.USD","IE00B4JS1V06.HKD","BNTX","LU2476274308.USD","LU1201861249.SGD","LU2148510915.USD","PJP","XLV","LU0256863902.USD","LU2242652126.USD","LU0689472784.USD","LU1720051108.HKD","LU1244550577.SGD","LU0868494617.USD","SG9999015952.SGD","LU2097828631.EUR","LU2237443382.USD","LU1291159041.SGD","LU0942090050.USD","LU2111349929.HKD","IE00BBT3K403.USD","LU0310800379.SGD","LU2023250843.SGD","LU1267930490.SGD","LU0345777147.USD","LU1699723380.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","SG9999003800.SGD","LU2746668974.SGD","LU0316494557.USD","LU2039709279.SGD","SG9999018865.SGD","03692","IE000M9KFDE8.USD","LU2089984988.USD","LU0098860793.USD","LU0133085943.USD","ABBV","LU1941712348.USD","LU1983299246.USD","LU1273509221.SGD","BK4139","LU1670711123.USD","RHHBY","BK4535","LU1116320901.HKD","LU2756315664.SGD","LU0266013472.USD","SG9999001176.SGD","LU2362541513.USD","LU1037948897.HKD","LU2456880835.USD","LU2087625088.SGD","BK1515","LU2129689431.USD","LU1152091754.HKD","LU0161305163.EUR","LU0130102774.USD","IE000WAW04H5.SGD","LU0052756011.USD","LU1820825898.SGD","LU0499090636.EUR","SG9999014567.USD","FTXH","LU0265550946.USD","LU0171293334.USD","LLII","LU2476274720.SGD","LU0868494708.USD","BK1521","LU1548497426.USD","LU1880407215.USD","LU2471134796.USD","SGXZ99366536.SGD","BK4533","LU2211815571.USD","RXL","LU2552382215.SGD","LU1629891620.HKD","IE00BKPKM429.USD","LU1712237335.SGD","LU1814569148.SGD","SG9999004220.SGD","LU1008478684.HKD","LU1116320737.USD","TRUH","IE00BFSS7M15.SGD","LU1226287792.SGD","MEDX","LU2328871848.SGD","LU1267930813.SGD","LU1104425308.USD","LU0417517546.SGD","LU0203347892.USD","LU0077335932.USD","IE00BZ08YT58.USD","LU0210536198.USD","LU0238689110.USD","LU1261432733.SGD","LU0385154629.USD","LU0882574055.USD","LU1934455194.USD","IE0009355771.USD","LU0820561909.HKD","BK1593","BK4566","LU2133065610.SGD","LU2746668461.USD","LU0158827781.USD","LU2491050154.USD","HK0000165453.HKD","LU1585245621.USD","LU1098665638.USD","IE0000B7K699.USD","LU1670710588.SGD","IE00B7KXQ091.USD","LU0889565080.SGD","LU2023250330.USD","01276","LU0820562030.AUD","LU2097828714.EUR","LU0029864427.USD","LU2279689827.SGD","LU1831875114.USD","BK1161","LU0058720904.USD","LU1035773651.USD","LU1064130708.USD","LU0225771236.USD","LU0471298694.HKD","LU0553294199.USD","LU0607220059.USD","BK1574","IE00BGHQF631.EUR","LU0466842654.USD","LU0211328371.USD","SG9999002224.SGD","LU2242644610.SGD","SG9999014575.USD","LU0823434583.USD","LU0672654240.SGD","LU2347655073.USD","AZN.UK","LU2023251221.USD","LU2168564065.EUR","LU0128525689.USD","LU1328615791.USD","LU0289739699.SGD","LU2357305700.SGD","LU2360106947.USD","IE0004445239.USD","LU0109391861.USD","LU1226288170.HKD","LU0198837287.USD","LU0823399737.USD","LU1267930730.SGD","IE0001KFT4U8.USD","IE00BJJMRZ35.SGD","LLYZ","PFE","LU0648001328.SGD","LU0997586432.USD","LU1400636657.SGD","LU0314109678.HKD","LU2087621335.USD","GDOC","LU0708995401.HKD","LU1400636491.USD","01530","LU2271345857.HKD","LU0158827948.USD","LU0149534421.HKD","LU0315179316.USD","LU0985320562.USD","LU1232071149.USD","BK0188","LU1720051017.SGD","LU2106854487.HKD","LU1794554557.SGD","LU0072461881.USD","LU0987226296.USD","LU1974910355.USD","BK4588","LU1152091168.USD","LU0211326839.USD","LU1807302812.USD","LU1037948541.HKD","LU0957799991.USD","BK0060","LU0786609619.USD","LU1934455863.HKD","LU0348783233.USD","LU0140636845.USD","LU1035777561.USD","LU0006306889.USD","LU0265550359.USD","LU1691799644.USD","LU1829250122.USD","IE00BZ08YR35.GBP","IE00BJLML261.HKD","LU2347655156.SGD","LU2168563687.JPY","ELIS","LU0857590862.USD","LU1551013342.USD","LU0540923850.HKD","LU0792757196.USD","LU1093756325.SGD","LU2168564149.EUR","LU0880133367.SGD","LU1127390331.HKD","IE000SO60NU8.SGD","LU0738911758.USD","IE0004445015.USD","LU1066051225.USD","LU0575583348.USD","LU1301847155.USD","LU2237443465.HKD","LLYX","IE00BFSS8Q28.SGD","LU1202635105.USD","LU1066051498.USD","LU2114397693.USD","LU1146622755.USD","LU0094547139.USD","LU0920783379.SGD","IE00BKVL7J92.USD","LU0174119429.USD","LU1917777945.USD","LU0463099449.HKD","LU2264538146.SGD","LU2237443622.USD","LU1720050803.USD","LU2361045086.USD","LU0455707207.USD","BK4516","LU0289739343.SGD","LU0096364046.USD","LU1670756490.USD","LU0545039389.USD","IE000MB6IJN5.SGD","LU0097036916.USD","LU1323610961.USD","LU0225283273.USD","09995","LU0109981661.USD","LU0170899867.USD","BK4007","LU1078025761.USD","SG9999018857.SGD","LU1069344957.HKD","LU2236285917.USD","LU0960981461.USD","LU0949170426.SGD","LU2468319806.SGD","IE00B5MMRT66.SGD","IE00BVYPNW00.USD","LU1019632923.USD","LU1066053197.SGD","LU1015430645.USD","IE00BQJZX424.USD","01801","LU1066051811.HKD","WDNA","LU1868837136.USD","IBB","IE000F7OJYX1.SGD","CANC","BK1191","OZEM","LU1645745479.HKD","LU0471298777.SGD","LU2778985437.USD","LU1929549753.HKD","LU1430594728.SGD","THNR","IE00BN8TJ469.HKD","LU1989771016.USD","LU0920840948.USD","BK4550","LU1061106388.HKD","LU1997245177.USD","IE00B19Z3B42.SGD","SG9999013999.USD","LU1074936037.SGD","SGXZ81514606.USD","03933","LU0310799852.SGD","LU0965509010.AUD","LU1236620834.HKD","LU0234572021.USD","LU0689626769.HKD","LU0208291251.USD","NVOC","BK4534","LU0395794307.EUR","LU0417516902.SGD","LU1244550494.USD","BBH","LU0320765489.SGD","LU1732800096.USD","SG9999014898.SGD","LU2112291526.USD","LU1813983027.USD","LU1119994496.HKD","LU1046248800.SGD","LU1162221912.USD","LU0823416689.USD","LU1196032939.SGD","LU1093756168.USD","LU0787776722.HKD","LU1019634622.SGD","02096","GB00BDT5M118.USD","IE00BVYPNV92.GBP","LU0971552830.HKD","LU0795875169.SGD","LU0971552673.USD","LU0211327993.USD","LU0496365809.HKD","SG9999015978.USD","BK0012","LU1064131342.USD","LU2580892862.HKD","IE00B3T34201.USD","LU1880407132.USD","SG9999014542.SGD","03165","LU1989772923.USD","BK4532","LU2265009873.SGD","PAWZ","LU0511384066.AUD","IE00B775H168.HKD","BMED","BK1583","LU2602419157.SGD","IE00BJJMRX11.SGD","LU2580892789.USD","LU0683600562.USD","SG9999014914.USD","BK4599","IE00B1XK9C88.USD","IE00BPRC5H50.USD","SG9999015341.SGD","LU2237443978.SGD","LU0985481810.HKD","LU2471134523.USD","BMY","LU0417516571.SGD","LU0326950275.SGD","LU2417539215.USD","LU2462591350.SGD","LU2361044865.SGD","LU1170363599.USD","LU0561508036.HKD","LU1868836757.USD","LU1670710661.SGD","SMMT","LU0963555726.SGD","00013","LU2896262040.SGD","LU1961090484.USD","LU1979441026.SGD","LU0997586515.USD","LU2237438978.USD","LU1804176565.USD","IE00BN29S564.USD","IE0034235071.USD","LU0203202063.USD","LU0323591593.USD","LU0784384876.USD","LU2089284900.SGD","LU2237443895.HKD","BK4548","LU1571399168.USD","LU0321505868.SGD","NVS","LU0306807586.USD","IE00BSNM7G36.USD","09926","LU2213496289.HKD","LU1951186391.HKD","LU2471134952.CNY","LU0477156953.USD","BK4581","LU0726765562.USD","FHLC","LU0348735423.USD","TBXU","IE0034235188.USD","LU0345770993.USD","LU0310800965.SGD","JDOC","LU2125154935.USD","LU0859254822.USD","LU2362541273.HKD","LU2491050071.SGD","LU2552382132.HKD","LU0122379950.USD","LU1267930573.SGD","IE00BJJMRY28.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672137097","title":"Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672137097","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672137097?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:35","pubTimestamp":1790933700,"startTime":"0","endTime":"0","summary":"0934 GMT - Sanofi and Regeneron Pharmaceuticals' potential successors to blockbuster medicine Dupixent might lag behind rival drugs Pfizer and AbbVie are developing, Citi analysts say in a research note. The new experimental drugs Sanofi and Regeneron will jointly develop under their alliance focus solely on extending the dosing interval of Dupixent without compromising efficacy or tolerability, but there is no expectation of a superior performance, Citi says. This suggests those medicines might struggle to compete with Pfizer's tilrekimig and AbbVie's zumilokibart, both of which have shown potential for better efficacy in midstage trials, according to Citi. Moreover, it might be challenging for Sanofi and Regeneron to get reimbursement for those drugs from healthcare payers after copycat versions of Dupixent become available, the analysts add. Sanofi shares fall 3.4%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU0211327993.USD","LU2106854487.HKD","LU0965509283.SGD","ABBV","JDOC","LU1037948541.HKD","IXJ","TBXU","PJP","LU0098860793.USD","LU0795875169.SGD","IBBQ","LU0949170772.SGD","VHT","LU2112291526.USD","XLV","LU0158827948.USD","LU1244550577.SGD","SNY","FTXH","GLAM","SNYNF","LU0069063385.USD","LU0057025933.USD","MEDX","LU1720051108.HKD","AGNG","BBH","FHLC","TRUH","LU1883839398.USD","BK4585","LU0417517546.SGD","IE00BJT1NW94.SGD","REGN","OZEM","LU0128525929.USD","LU2347655073.USD","BK4599","IBB","LU1917777945.USD","IYH","LU0029864427.USD","LU0203347892.USD","PPH","PFE","LU2133065610.SGD","RXL","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672790916","title":"Novartis Strikes up to $7.8 Billion mRNA Deal with China's Abogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2672790916","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672790916?lang=en_us&edition=fundamental","pubTime":"2026-10-02 15:57","pubTimestamp":1790927874,"startTime":"0","endTime":"0","summary":"UPDATE 3-Novartis strikes up to $7.8 billion mRNA deal with China's AbogenOct 2 (Reuters)-Chinese biotech company Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Nov","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1814569148.SGD","GNOM","PPH","IDNA","VHT","PAWZ","LU0162691827.USD","AZN.UK","BK4007","LU1051770623.HKD","GDOC","IE00BKPKM643.USD","LGHT","FTXH","WDNA","IE00BLSP4239.USD","LU0171293334.USD","LU0942090050.USD","LU1291159041.SGD","LU1430594728.SGD","LU1989771016.USD","LU0011850046.USD","03165","LU2112291526.USD","FHLC","MRNA","LU0070302665.USD","MRNY","BMED","IHE","IXJ","LU1880407132.USD","XLV","LU0098860793.USD","LU0976567544.SGD","LU1261432733.SGD","SG9999015358.SGD","TRUH","LU0757432116.USD","HRTS","JDOC","IYH","LU0920783379.SGD","MRK","LU0823416689.USD","LU2106854487.HKD","RXL","MRNX","LU0203347892.USD","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672916767","title":"Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672916767","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672916767?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:28","pubTimestamp":1790890080,"startTime":"0","endTime":"0","summary":"DJ Perrigo Co. PLC Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Perrigo Co. PLC  slid 5.01% to $14.02 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.19% to 7,666.45 and the Dow Jones Industrial Average  rising 0.04% to 50,926.56.This was the stock's fourth consecutive day of losses.Perrigo Co. PLC closed 38.10% below its 52-week high of $22.65, which the company reached on October 3rd.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.30% to $258.66, Procter & Gamble Co.  fell 0.92% to $143.95, and Abbott Laboratories  fell 2.17% to $96.69.Trading volume  remained 247,637 below its 50-day average volume of 2.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","IE00B19Z3581.USD","LU0345769631.USD","TMED","JDOC","LU1221951129.SGD","SGXZ80539844.SGD","LU0994945656.USD","LU1721429741.USD","LU0289739699.SGD","SG9999002232.USD","LU2112291526.USD","IXJ","LU1721429402.USD","LU1718418525.SGD","IHI","LU1551013425.SGD","IE000WAW04H5.SGD","LU0289739343.SGD","LU2552382132.HKD","XLP","XLV","IE00B3PB1722.GBP","MEDX","GDOC","IE000F7OJYX1.SGD","PJP","FSTA","IYH","TRUH","LU0069063385.USD","PG","LU1043141396.HKD","FHLC","IHE","IE00BLSP4452.SGD","UGE","SG9999015341.SGD","LU1506573853.SGD","FTXH","PRGO","TRUO","ABT","LU0289961442.SGD","BK4534","JNJ","LU1162221912.USD","RXL","VHT","SGXZ23171101.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672629967","title":"Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2672629967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672629967?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:37","pubTimestamp":1790887025,"startTime":"0","endTime":"0","summary":"The latest update is out from Nanobiotix ( ($FR:NANO) ). Nanobiotix is a late‑stage French biotechnology company developing physics‑based therapeut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","FHLC","JDOC","SYNB","IEIH","XBIX","AGNG","FWD","BBP","IBB","BK4588","NANO","NVIB","RSPH","DARP","BK4585","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672762679","title":"Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2672762679","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672762679?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:33","pubTimestamp":1790886780,"startTime":"0","endTime":"0","summary":"DJ Merck & Co. Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Merck & Co. Inc.  slipped 1.03% to $143.81 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.19% to 7,666.45 and the Dow Jones Industrial Average  rising 0.04% to 50,926.56.This was the stock's second consecutive day of losses.Merck & Co. Inc. closed 8.35% short of its 52-week high of $156.92, which the company reached on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.30% to $258.66, Pfizer Inc.  fell 1.40% to $28.12, and Eli Lilly & Co.  fell 0.62% to $1,149.85.Trading volume  remained 2.2 million below its 50-day average volume of 10.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","LU0965509283.SGD","LU0266013472.USD","LU0511384066.AUD","IE00BBT3K403.USD","IXJ","LU0432979614.USD","LU1116320901.HKD","LU2324357040.USD","LU1037948897.HKD","LU0098860793.USD","LU0823416689.USD","LU1116320737.USD","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","IE0002141913.USD","LU1291159041.SGD","IE00BSNM7G36.USD","LU0162691827.USD","LU1162221912.USD","SG9999001176.SGD","LU0289739699.SGD","LU2491049909.HKD","BK4585","BMED","IE00BJT1NW94.SGD","LU1974910355.USD","LU1035773651.USD","LU1023059063.AUD","LU0211331839.USD","LU0942090050.USD","LU0689626769.HKD","LU0203345920.USD","BK4007","LU1066053197.SGD","LU1934455194.USD","LU0289961442.SGD","LU0868494617.USD","IYH","LU2361044949.HKD","LU0861579265.USD","LU1061106388.HKD","LU1934455277.USD","LU0320765646.SGD","LU2106854487.HKD","SG9999014542.SGD","LU2361045086.USD","SG9999013999.USD","JDOC","LU0070302665.USD","LU1069347547.HKD","IE00B4R5TH58.HKD","GDOC","LU1941712264.USD","VHT","LU2112291526.USD","BK4516","IE00B2B36J28.USD","LU0069063385.USD","LU0057025933.USD","IE0009355771.USD","TRUH","LU0234572021.USD","BK4588","LU0980610538.SGD","LU0006306889.USD","LU1066051498.USD","SG9999014575.USD","HRTS","LU0320765489.SGD","LU1430594728.SGD","LU1093756168.USD","SG9999001176.USD","LU2125154935.USD","LU0130517989.USD","LU0203347892.USD","LU1093756325.SGD","LU2491050071.SGD","LU1934455863.HKD","LU0122379950.USD","IE00BLSP4452.SGD","LU1066051225.USD","LU1057294990.SGD","LU0477156953.USD","LU0238689110.USD","LU2360032135.SGD","LU1923622614.USD","LU2023250843.SGD","LU1037948541.HKD","SG9999001440.SGD","LU1201861249.SGD","SG9999014567.USD","LU0265550359.USD","LU1699723380.USD","LU0472753341.HKD","LU2461242641.AUD","LU2125154778.USD","FTXH","LU1032466523.USD","LU0965509101.SGD","LU2468319806.SGD","LU1571399168.USD","LU1585245621.USD","SG9999014559.SGD","SG9999002224.SGD","FHLC","LU0124676726.USD","LU0058720904.USD","LU2491050154.USD","MRK","IE000M9KFDE8.USD","BK4534","IE00BLSP4239.USD","LU2433249047.HKD","LU0648001328.SGD","LU1917777945.USD","LU2089984988.USD","LU0289739343.SGD","PPH","LU0965509010.AUD","RXL","LU0868494708.USD","LU1929549753.HKD","LU1989772923.USD","LU1989771016.USD","LU2125909593.SGD","PAWZ","LU1066051811.HKD","LU1941712348.USD","IHE","IE00BFTCPJ56.SGD","LU2361044865.SGD","LU0859254822.USD","LU2357627491.SGD","LU0265550946.USD","BK4533","LU2125909247.SGD","SG9999002232.USD","XLV","BK4550","LU0072461881.USD","LU0985320562.USD","LU0965508806.USD","LU1983299246.USD","LU2023250504.SGD","IE00BN8TJ469.HKD","LU0106261372.USD","LU1989772840.SGD","SG9999015358.SGD","LU0208291251.USD","SG9999015341.SGD","LU0130102774.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672783761","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2672783761","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672783761?lang=en_us&edition=fundamental","pubTime":"2026-10-02 03:29","pubTimestamp":1790882992,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined late Thursday afternoon, with the NYSE Healthcare Index falling 1% and the State Street Health Care Select Sector SPDR ETF  dropping 1.1%.The iShares Biotechnology ETF  shed 1.6%.In corporate news, Foghorn Therapeutics  and Eli Lilly  have decided not to advance FHD-909 into the clinical development expansion phase after reviewing clinical data from a phase 1 dose escalation trial. Foghorn shares fell 16%, and Lilly was down 0.2%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0225283273.USD","LLII","LU1057294990.SGD","LU1548497426.USD","LU2471134796.USD","SG9999014880.SGD","LU0256863811.USD","SGXZ99366536.SGD","BK4533","LU2211815571.USD","BK4007","PPH","LU2023250504.SGD","RXL","LU1988902786.USD","LU1069344957.HKD","LU2236285917.USD","SG9999018857.SGD","LU2468319806.SGD","LU2552382215.SGD","LU1629891620.HKD","IE00BKPKM429.USD","IE00B1BXHZ80.USD","LU1712237335.SGD","LU1814569148.SGD","SG9999015945.SGD","LU1145028129.USD","LU1366192091.USD","WDNA","LU2491049909.HKD","LU1868837136.USD","SG9999015986.USD","TRUH","IBB","IE00BFSS7M15.SGD","LU2750360997.AUD","MEDX","LU1035775433.USD","LU1868836914.USD","CANC","OZEM","LU0417517546.SGD","LU0238689110.USD","IE00BJT1NW94.SGD","LU0210536198.USD","LU0432979614.USD","LU0471298777.SGD","LU0385154629.USD","LU0882574055.USD","LU1280957306.USD","LU2361044949.HKD","MEDI","LU0106261372.USD","BK4585","IE0009355771.USD","LU0820561909.HKD","THNR","LU1989771016.USD","MHIP","SG9999017495.SGD","IE00BWXC8680.SGD","LU1023059063.AUD","LU1061106388.HKD","FTXH","SG9999013999.USD","LU2746668461.USD","LABU","SGXZ81514606.USD","LU0158827781.USD","LU2491050154.USD","LU0345770308.USD","LU0353189680.USD","IE0005OL40V9.USD","IE00B7KXQ091.USD","LU2023250330.USD","LU0820562030.AUD","LU0234572021.USD","LU0058720904.USD","ILDR","TMED","LU0471298694.HKD","LU2750360641.GBP","SGXZ51526630.SGD","LU0466842654.USD","LU0820561818.USD","LU2237443549.SGD","BK4534","LU0203201768.USD","SG9999014898.SGD","LU2471134879.HKD","LU0823434583.USD","LU0672654240.SGD","LU2112291526.USD","LU2023251221.USD","LU2168564065.EUR","XBI","LU0289739699.SGD","LU2357305700.SGD","LU2360106947.USD","LU2168564495.EUR","IXJ","VHT","LU0823416689.USD","LU0354030511.USD","LU1093756168.USD","LU0787776722.HKD","FHTX","GB00BDT5M118.USD","IE0004445239.USD","LU2089283258.USD","LU0079474960.USD","LU2462157665.USD","LU0109391861.USD","SG9999015978.USD","LLY","LU0198837287.USD","LU0354030438.USD","LU1064131342.USD","LU0882574139.USD","IE0001KFT4U8.USD","IE00BJJMRZ35.SGD","LU1267930730.SGD","LU1868837300.USD","SGXZ31699556.SGD","LLYZ","LU1623119135.USD","IE00BK4W5L77.USD","LU0320765992.SGD","LU2265009873.SGD","GDOC","LU0708995401.HKD","LU0456855351.SGD","LU0889565916.HKD","SG9999014906.USD","AGNG","IE00B775H168.HKD","LU2271345857.HKD","LU0158827948.USD","LU2602419157.SGD","IE00BKDWB100.SGD","LU1232071149.USD","IE00BJJMRX11.SGD","CURE","LU0683600562.USD","LU1720051017.SGD","SG9999014914.USD","BK4599","LU2106854487.HKD","IE00B1XK9C88.USD","LU1974910355.USD","IYH","BK4588","LU0640476718.USD","LU2237443978.SGD","LU2471134523.USD","LU2108987350.USD","LU1868836591.USD","IE00B4JS1V06.HKD","LU2417539215.USD","LU0786609619.USD","LU2462591350.SGD","LU0943347566.SGD","LU2361044865.SGD","SG9999001176.USD","PJP","XLV","LU0256863902.USD","LU2324357040.USD","LU0006306889.USD","LU0689472784.USD","LU1691799644.USD","LU1720051108.HKD","LU1868836757.USD","IE00BK4W5M84.HKD","LU2168564222.USD","SG9999015952.SGD","ELIL","IE00BJLML261.HKD","LU2168563687.JPY","LU2237443382.USD","IHE","LU2896262040.SGD","LU1979441026.SGD","LU0353189763.USD","LU1291159041.SGD","LU2111349929.HKD","LU2237438978.USD","ELIS","LU1551013342.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU1804176565.USD","LU1093756325.SGD","LU0109394709.USD","IE00BN29S564.USD","LU0203202063.USD","LU0323591593.USD","LU2168564149.EUR","LU2089284900.SGD","LU1127390331.HKD","HRTS","LU0964807845.USD","LU2237443895.HKD","LU2746668974.SGD","LU2063271972.USD","IE00B2B36J28.USD","IE0004445015.USD","LU0316494557.USD","SG9999018865.SGD","LU2089984988.USD","LU2552382058.USD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2237443465.HKD","LLYX","LU0133085943.USD","IE00BFSS8Q28.SGD","LU1983299246.USD","LU2461242641.AUD","BK4139","LU2213496289.HKD","LU0094547139.USD","IE0002141913.USD","SGXZ57979304.SGD","LU0823434740.USD","LU2471134952.CNY","LU2756315664.SGD","LU2756315318.SGD","LU0266013472.USD","BK4581","LU0174119429.USD","LU1917777945.USD","LU2028103732.USD","LU2264538146.SGD","FHLC","SG9999001176.SGD","LU2456880835.USD","LU2087625088.SGD","LU2237443622.USD","LU0345770993.USD","LU2361045086.USD","JDOC","LU0061475181.USD","BK4516","LU0096364046.USD","LU2491050071.SGD","LU2552382132.HKD","LU0097036916.USD","LU0114720955.EUR","LU0122379950.USD","IE00BJJMRY28.SGD","LU1323610961.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672480761","title":"AbbVie (ABBV) Stock May Be 41% Undervalued On FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2672480761","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672480761?lang=en_us&edition=fundamental","pubTime":"2026-10-02 02:21","pubTimestamp":1790878886,"startTime":"0","endTime":"0","summary":"AbbVie’s AbbVie stock has had a strong multiyear run, and with the price recently closing at US$261.59, the key issue is whether that level is backed by the cash the business is expected to generate. Recent drug approvals, partnerships and data readouts all feed into those future cash flows, which is where the valuation debate now sits.\n\nOver the past 5 years AbbVie has delivered a total return of 187.5%, which puts real weight on the question of whether the current share price is fully...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-stock-may-be-41-undervalued-on-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-stock-may-be-41-undervalued-on-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1093756168.USD","LU2089284900.SGD","LU2433249047.HKD","SG9999011175.SGD","LU2125909247.SGD","GLAM","LU0868494617.USD","VHT","LU0114720955.EUR","LU0859254822.USD","LU1670627923.USD","ABBV","BK4581","IYH","LU0726765562.USD","LU0689626769.HKD","DCF","LU1430594728.SGD","LU1929549753.HKD","RXL","LU2347655073.USD","TRUH","JDOC","LU1037948541.HKD","MEDX","LU1989772840.SGD","LU1244550221.USD","LU2129689514.USD","LU0472753341.HKD","XLV","LABU","LU0965508806.USD","IE00B4R5TH58.HKD","BK4588","LU0795875169.SGD","AGNG","LU1720051017.SGD","PPH","PJP","IXJ","LU0256863902.USD","FTXH","FHLC","BK4533","LU2089984988.USD","LU2468319806.SGD","SPHQ","LU1670628061.USD","LU2125909593.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672769149","title":"Trump Medicare Drug Pricing Model May Apply to Only Four Companies After Exemptions","url":"https://stock-news.laohu8.com/highlight/detail?id=2672769149","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672769149?lang=en_us&edition=fundamental","pubTime":"2026-10-02 01:54","pubTimestamp":1790877298,"startTime":"0","endTime":"0","summary":"Trump Medicare drug pricing model may apply to only four companies after exemptionsNEW YORK, Oct 1 (Reuters)-A Trump administration rule to cut hospital drug prices for Medicare patients may apply to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL1N45N0WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014898.SGD","LU0323591593.USD","LU2491049909.HKD","LU2746668461.USD","LU2491050071.SGD","LU0823434583.USD","LU2237443382.USD","PPH","LU1629891620.HKD","JDOC","FHLC","LU1917777945.USD","LU0823434740.USD","LU0354030511.USD","LU0225771236.USD","LU0256863811.USD","LU0306807586.USD","LU2265009873.SGD","FTXH","IE00BJLML261.HKD","LU0079474960.USD","LU2089283258.USD","LU2324357040.USD","LU2750360997.AUD","SG9999017495.SGD","LU1291159041.SGD","IE00B1BXHZ80.USD","LU0786609619.USD","BK4581","LU1712237335.SGD","LU0061475181.USD","LU0985481810.HKD","LU2361044865.SGD","LU0203202063.USD","LU2361045086.USD","SG9999014880.SGD","IE00B19Z3581.USD","LU2361044949.HKD","LU2023251221.USD","SGXZ51526630.SGD","LU2237443549.SGD","IE00B19Z3B42.SGD","LU0114720955.EUR","LU0353189763.USD","SG9999014906.USD","IE0002141913.USD","LLY","IE00B3T34201.USD","LU0820561909.HKD","LU0964807845.USD","IE0009355771.USD","IE00B775H168.HKD","LU2552382215.SGD","LU1093756168.USD","LU0640476718.USD","IE00BJJMRX11.SGD","IE00BKDWB100.SGD","BK4588","LU0354030438.USD","SGXZ31699556.SGD","LU0122379950.USD","LU0096364046.USD","BK4592","LU0210536198.USD","LU2106854487.HKD","BK4533","IE00BJJMRZ35.SGD","LU2168564065.EUR","BK4007","LU0820562030.AUD","LU0466842654.USD","LU2552382058.USD","IE00BK4W5M84.HKD","LU0198837287.USD","LU1057294990.SGD","LU2168564222.USD","SGXZ99366536.SGD","IE00BFTCPJ56.SGD","LU0203201768.USD","LU0316494557.USD","LU0471298694.HKD","LU2168564495.EUR","LU2271345857.HKD","LU1127390331.HKD","AGNG","LU0170899867.USD","LU0385154629.USD","RXL","IE0005OL40V9.USD","LU0708995401.HKD","LU0094547139.USD","LU2756315664.SGD","LU2471134796.USD","SG9999015986.USD","LU0225283273.USD","LU0320765059.SGD","LU1814569148.SGD","IE000M9KFDE8.USD","LU1868837136.USD","THNR","LU2112291526.USD","OZEM","GB00BDT5M118.USD","LU1069344957.HKD","LU2471134523.USD","SG9999018857.SGD","IE00BLSP4452.SGD","SG9999002224.SGD","LU2213496289.HKD","LU1868836591.USD","LU1894683264.USD","LU2237443978.SGD","LU2028103732.USD","LU0882574055.USD","LU2089984988.USD","LU2456880835.USD","BK4550","LU2417539215.USD","IE00B2B36J28.USD","LU0234572021.USD","IE0002270589.USD","SGXZ57979304.SGD","LU0787776722.HKD","MHIP","LU0868494617.USD","LLYX","LU1023059063.AUD","IE00BWXC8680.SGD","LU0109394709.USD","LU0672654240.SGD","LU2087625088.SGD","LU0158827781.USD","LU2237438978.USD","LU0109391861.USD","LU1691799644.USD","SG9999014914.USD","LU1093756325.SGD","LU1720051108.HKD","SG9999001176.SGD","LU2896262040.SGD","IE00BFSS7M15.SGD","MEDX","LU2168564149.EUR","LU1323610961.USD","LU2237443895.HKD","LU1883839398.USD","WDNA","ELIS","LU2462591350.SGD","BK4599","SG9999018865.SGD","LU0256863902.USD","LU1551013425.SGD","LU2108987350.USD","LU2756315318.SGD","LU0238689110.USD","LU0345770308.USD","LU2211815571.USD","PJP","LU2462157665.USD","LU0320765992.SGD","LU0345770993.USD","LU1366192091.USD","LU2750360641.GBP","SGXZ81514606.USD","LU0820561818.USD","LLII","LU1061106388.HKD","LU1145028129.USD","LU2111349929.HKD","IE00BFSS8Q28.SGD","LU0417517546.SGD","LU2237443622.USD","LU2237443465.HKD","LU1720051017.SGD","LU2596442595.SGD","LU1974910355.USD","IE00BKPKM429.USD","LU2491050154.USD","LU2552382132.HKD","SG9999015952.SGD","LU2746668974.SGD","LU0456855351.SGD","LU0106261372.USD","LU2063271972.USD","VHT","XLV","BK4534","LU2023250330.USD","PFE","SG9999002232.USD","LU1979441026.SGD","LU1548497426.USD","LU0289739699.SGD","LU0158827948.USD","HRTS","LU0943347566.SGD","LU1551013342.USD","LU0174119429.USD","LU0006306889.USD","IE00B4JS1V06.HKD","SG9999013999.USD","IE00BLSP4239.USD","IE00BBT3K403.USD","LU0689472784.USD","SG9999001176.USD","SG9999015945.SGD","IE0001KFT4U8.USD","CANC","IE00BJJMRY28.SGD","LU1983299246.USD","LU2468319806.SGD","LLYZ","LU0823416689.USD","LU1064131342.USD","LU1894683348.USD","LU1623119135.USD","IE00B7KXQ091.USD","TMED","BK4585","LU2357305700.SGD","LU1267930730.SGD","LU0471298777.SGD","LU0321505868.SGD","LU1232071149.USD","LU1868836757.USD","LU1989771016.USD","LU2023250504.SGD","IHE","LU2360106947.USD","SG9999011175.SGD","LU2264538146.SGD","ILDR","LU1280957306.USD","LU0882574139.USD","LU2471134952.CNY","LU2236285917.USD","GDOC","IE00B4R5TH58.HKD","LU0306806265.USD","IYH","LU0266013472.USD","LU0889565916.HKD","IE00B1XK9C88.USD","IE00BK4W5L77.USD","LU0432979614.USD","SG9999003800.SGD","BK4516","LU1035775433.USD","IE00BN29S564.USD","LU1804176565.USD","LU0097036916.USD","MEDI","CURE","IE00BJT1NW94.SGD","LU0058720904.USD","LU2168563687.JPY","IE0004445015.USD","LU1988902786.USD","LU2602419157.SGD","LU1868836914.USD","LU0683600562.USD","LU2471134879.HKD","ELIL","BK4568","TRUH","LU2089284900.SGD","LU2461242641.AUD","LU0225284248.USD","LU1066053197.SGD","LU0133085943.USD","LU0353189680.USD","LU1066051498.USD","SG9999015978.USD","IE0004445239.USD","IXJ","LU0321505439.SGD","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672766900","title":"Merck's Tulisokibart Data From Hidradenitis Suppurativa Trial Looks Solid, UBS Securities Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672766900","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672766900?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:38","pubTimestamp":1790872694,"startTime":"0","endTime":"0","summary":"Merck's  data from a phase 2b study evaluating tulisokibart in hidradenitis suppurativa looks solid, potentially adding another indication for tulisokibart as management plans to advance into a phase 3 trial, UBS Securities said in a note Wednesday.The company reported a 29% to 37% placebo adjusted hidradenitis suppurativa clinical response 50 between the four-week dose and two-week dose at week 16, which appeared to be in-line or better than the phase 2 data from UCB's Bimzelx, the investment firm said.Even if phase 3 efficacy comes down slightly, UBS said tulisokibart could still be a meaningfully differentiated product as a novel mechanism compared with current standard of care.As tulisokibart can be dosed either at a two-week interval or a four-week interval, the investigational drug could be priced slightly higher with potentially more frequent dosing for the hidradenitis suppurativa indication, the firm said.UBS Securities has a buy rating on the stock, with a $175 price target.M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BN8TJ469.HKD","LU2125154778.USD","BK4534","LU0965509283.SGD","LU2023250843.SGD","LU0072461881.USD","LU2491050154.USD","LU2461242641.AUD","IE00B1BXHZ80.USD","LU0320765646.SGD","IE00BBT3K403.USD","BK4516","LU0823416689.USD","LU0648001328.SGD","LU1093756168.USD","LU1974910355.USD","LU0265550359.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","SG9999013999.USD","SG9999001176.SGD","LU0868494617.USD","LU0162691827.USD","SGXZ57979304.SGD","LU2491050071.SGD","LU2357627491.SGD","LU0266013472.USD","LU1066051498.USD","LU0985320562.USD","SG9999002232.USD","LU0106261372.USD","LU2106854487.HKD","LU2125909593.SGD","FHLC","LU1116320901.HKD","LU1066051225.USD","LU1037948541.HKD","LU0130102774.USD","IE00BLSP4239.USD","IE00B4R5TH58.HKD","LU0203347892.USD","LU1162221912.USD","LU1571399168.USD","TRUH","LU0098860793.USD","IE00BFTCPJ56.SGD","LU1934455194.USD","LU0432979614.USD","VHT","LU0965509010.AUD","BK4550","IE000M9KFDE8.USD","LU0859254822.USD","LU1941712348.USD","IHE","LU0265550946.USD","LU0965509101.SGD","LU1057294990.SGD","LU1585245621.USD","LU1066051811.HKD","LU0861579265.USD","LU0203345920.USD","SG9999001176.USD","LU0289961442.SGD","SG9999015341.SGD","LU0122379950.USD","PAWZ","LU1035773651.USD","LU0124676726.USD","LU0069063385.USD","BK4588","LU1989772840.SGD","LU0057025933.USD","IE00BSNM7G36.USD","LU1023059063.AUD","IE0009355771.USD","JDOC","IE00B2B36J28.USD","LU2468319806.SGD","LU1037948897.HKD","MRK","LU2023250504.SGD","LU2125154935.USD","LU0238689110.USD","IE00BLSP4452.SGD","LU0208291251.USD","LU0689626769.HKD","SG9999014575.USD","LU1291159041.SGD","LU1923622614.USD","LU0965508806.USD","LU2361044865.SGD","LU1983299246.USD","LU2360032135.SGD","LU0289739699.SGD","SG9999014542.SGD","HRTS","LU0006306889.USD","IXJ","LU1929549753.HKD","LU2089984988.USD","LU1066053197.SGD","LU0477156953.USD","IE00BJT1NW94.SGD","LU0211331839.USD","LU0980610538.SGD","LU0289739343.SGD","LU0868494708.USD","LU1069347547.HKD","LU2361045086.USD","SG9999014567.USD","XLV","LU1032466523.USD","LU2433249047.HKD","GDOC","LU2112291526.USD","LU1201861249.SGD","LU1941712264.USD","LU1093756325.SGD","LU0472753341.HKD","RXL","LU0511384066.AUD","BK4585","LU2324357040.USD","LU2491049909.HKD","FTXH","BMED","SG9999001440.SGD","IYH","LU0130517989.USD","IE0002141913.USD","LU0320765489.SGD","LU1699723380.USD","SG9999015358.SGD","LU0058720904.USD","LU1934455863.HKD","BK4533","LU1116320737.USD","LU1061106388.HKD","BK4007","LU0070302665.USD","LU2361044949.HKD","PPH","LU2125909247.SGD","BK4559","LU1917777945.USD","LU1430594728.SGD","SG9999002224.SGD","SG9999014559.SGD","LU1934455277.USD","LU1989771016.USD","LU1989772923.USD","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672699766","title":"Eli Lilly's Obesity Data Support Broader Portfolio Beyond Tirzepatide, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672699766","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672699766?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:29","pubTimestamp":1790872162,"startTime":"0","endTime":"0","summary":"Eli Lilly's  new obesity data support a broader drug portfolio beyond tirzepatide, or TZP, UBS Securities said.The analysts said in a note Wednesday that the company presented new data at the European Association for the Study of Diabetes showing that its second- and third-generation obesity drugs can deliver more than 20% weight loss in both obesity and obesity patients with type 2 diabetes, with results that appear better than tirzepatide.UBS highlighted data for eloralintide plus tirzepatide, which showed strong weight-loss results broadly in line with retatrutide. Eloralintide could help patients who cannot tolerate GLP-1 drugs or do not lose enough weight, while retatrutide could offer another option for patients with higher liver fat, UBS said.The investment firm said Lilly is building a strong incretin portfolio beyond tirzepatide, with newer drugs offering additional treatment options and potentially superior efficacy.UBS has a buy rating and a $1,425 price target on Eli Lilly.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0210536198.USD","LU2462591350.SGD","LU2211815571.USD","IE00BJLML261.HKD","LU0432979614.USD","SGXZ31699556.SGD","IE0004445015.USD","IE00BJJMRX11.SGD","LU0943347566.SGD","LU1814569148.SGD","LU2023250504.SGD","SG9999001176.USD","IE00B1XK9C88.USD","LU2023251221.USD","LU0320765059.SGD","LU2264538146.SGD","LU0787776722.HKD","SG9999014880.SGD","LU2237443382.USD","LLII","LU2602419157.SGD","LU2237443549.SGD","IE00BKDWB100.SGD","IE0002141913.USD","LU2168563687.JPY","LU1551013342.USD","JDOC","LU2089984988.USD","LU2236285917.USD","SGXZ51526630.SGD","LU1989771016.USD","LU2552382132.HKD","MHIP","LU1623119135.USD","LU0316494557.USD","FTXH","LU0323591593.USD","LU1868836591.USD","SGXZ99366536.SGD","BK4534","LU2265009873.SGD","BK4599","LU0256863902.USD","LU2491050071.SGD","LU1868837300.USD","LU2237443465.HKD","BK4588","LU2461242641.AUD","LU0823434740.USD","LLYZ","SG9999018865.SGD","LU1069344957.HKD","LU1720051017.SGD","LU1232071149.USD","TRUH","CURE","IYH","LU1366192091.USD","SG9999017495.SGD","LU0174119429.USD","BK4585","MEDX","LU1983299246.USD","SG9999013999.USD","LU2089284900.SGD","LU0096364046.USD","ELIS","LU2108987350.USD","IE00BFSS7M15.SGD","LU2237438978.USD","LU2271345857.HKD","LU0234572021.USD","LU2357305700.SGD","OZEM","LU2361044865.SGD","LU0672654240.SGD","LU0823434583.USD","LU0058720904.USD","LU2168564065.EUR","LU1093756168.USD","IE00B4R5TH58.HKD","LU1551013425.SGD","IE00BJJMRY28.SGD","LU1917777945.USD","LU2456880835.USD","LU1093756325.SGD","LU2746668461.USD","LU2750360641.GBP","LU2237443978.SGD","PPH","SG9999015986.USD","BK4581","BK4516","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","BK4533","LU0385154629.USD","LU0114720955.EUR","LU1974910355.USD","LU1629891620.HKD","IE00BFTCPJ56.SGD","LU1720051108.HKD","LU0203201768.USD","LU0353189680.USD","LU1691799644.USD","LU2106854487.HKD","IE0009355771.USD","LU0158827781.USD","LU1064131342.USD","LU2168564495.EUR","LU1868836757.USD","LU0109391861.USD","LU0238689110.USD","LU0882574055.USD","VHT","IE00BFSS8Q28.SGD","SG9999014898.SGD","IHE","IE00BN29S564.USD","LU0823416689.USD","LU2491049909.HKD","LU0456855351.SGD","LU2063271972.USD","LU0354030438.USD","LU2750360997.AUD","IE00BK4W5M84.HKD","LU2471134523.USD","LU1057294990.SGD","ELIL","LU2756315664.SGD","LU1979441026.SGD","FHLC","SG9999015978.USD","LU2361045086.USD","LU0820562030.AUD","LU0640476718.USD","LU2023250330.USD","LU2896262040.SGD","LU1267930730.SGD","LU2361044949.HKD","LU2324357040.USD","SG9999014906.USD","LU1291159041.SGD","LU0689472784.USD","LU0158827948.USD","LU2087625088.SGD","LU0198837287.USD","LU0256863811.USD","LU2471134879.HKD","MEDI","LU1127390331.HKD","LU2168564149.EUR","LU0079474960.USD","LU0708995401.HKD","LU1868836914.USD","LU0882574139.USD","LU1023059063.AUD","SG9999001176.SGD","LU2112291526.USD","LU0097036916.USD","LU0006306889.USD","SG9999014914.USD","LU2471134796.USD","LU0683600562.USD","LU0094547139.USD","SG9999018857.SGD","LU0820561909.HKD","WDNA","LU0061475181.USD","LU2360106947.USD","IE00B7KXQ091.USD","LU0345770308.USD","SGXZ57979304.SGD","XLV","LU1280957306.USD","GDOC","LU0225283273.USD","LU0471298777.SGD","LU2491050154.USD","LU0266013472.USD","LU0786609619.USD","IE00B2B36J28.USD","LU2111349929.HKD","GB00BDT5M118.USD","LU2471134952.CNY","LU2746668974.SGD","LU1145028129.USD","LU2237443622.USD","IXJ","LU1988902786.USD","LU1868837136.USD","LU0889565916.HKD","LU2552382058.USD","LU2756315318.SGD","TMED","LU0106261372.USD","LU1712237335.SGD","SG9999015945.SGD","CANC","LU1548497426.USD","LU1323610961.USD","IE00BKPKM429.USD","SG9999015952.SGD","IE0001KFT4U8.USD","LU0320765992.SGD","LU0109394709.USD","LU2028103732.USD","LU2168564222.USD","RXL","LU0353189763.USD","LU2468319806.SGD","LU2237443895.HKD","LU2213496289.HKD","LU0345770993.USD","BK4007","IE0004445239.USD","ILDR","LLYX","LU0122379950.USD","LU0417517546.SGD","LU1035775433.USD","THNR","SGXZ81514606.USD","LU0354030511.USD","IE00BK4W5L77.USD","LLY","LU0289739699.SGD","IE00B4JS1V06.HKD","LU0820561818.USD","LU2552382215.SGD","LU0133085943.USD","PJP","IE0005OL40V9.USD","LU1061106388.HKD","AGNG","HRTS","LU0466842654.USD","LU0203202063.USD","LU1804176565.USD","LU2417539215.USD","IE00BWXC8680.SGD","LU0471298694.HKD","LU0964807845.USD","IE00B775H168.HKD","LU2089283258.USD","LU2462157665.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":3,"totalSize":333,"code":"91000000","status":"200"}]}}